NVCT - Nuvectis Pharma, Inc.
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
At close: 04:00PM EDT
After hours:
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 17.12 |
| Open | 17.15 |
| Bid | 17.05 x 800 |
| Ask | 17.55 x 800 |
| Day's Range | 17.08 - 17.82 |
| 52 Week Range | 6.21 - 17.82 |
| Volume | |
| Avg. Volume | 28,861 |
| Market Cap | 280.93M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research